Six-month flare risk after discontinuing long-term methotrexate treatment in patients having rheumatoid arthritis with low disease activity.
Jung Sun LeeJi Seon OhSeokchan HongYong-Gil KimChang-Keun LeeBin YooPublished in: International journal of rheumatic diseases (2020)
Among patients with RA who achieved low disease activity with long-term treatment with MTX, more than half remained flare free after MTX discontinuation. A higher MTX dose before discontinuation was associated with a high flare risk.